[The use of holoxan (iphosphamide) in malignant tumors]
Related Experiment Videos
Voprosy Onkologii
|January 1, 1990
Abstract:
A clinical trial of holoxan in combination with a urological protector--uromitexan--was carried out. Response was observed in 26.3% of patients with lung cancer. The drug was effective in cases of soft tissue sarcoma and Ewing's sarcoma.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Effects of fullerenol C₆₀(OH)₂₄ on erythropoiesis in vitro.
Bulletin of experimental biology and medicine·2014
[Which patients with ovarian cancer shows the combination of trabectedin with pegylated liposomal doxorubicin].
Vestnik Rossiiskoi akademii meditsinskikh nauk·2014
[The application of immunoglobulins for intravenous administration for the combined treatment of paratonsillar abscesses].
Vestnik otorinolaringologii·2012
[Experience in treating elderly patients with disseminated stomach and colon cancer].
Advances in gerontology = Uspekhi gerontologii·2003
[Diagnostic errors in patients with giant-cell tumor, bone cyst and osteosarcoma].
Voprosy onkologii·2019
[Inhibitory effect of RHAMM-target peptides on invasion of breast cancer cells].
Voprosy onkologii·2019
[Possibilities of local hyperthermia in treatment for edematous breast cancer patients].
Voprosy onkologii·2019
[Experience of 100 transthoracic needle biopsies of the lung under CT navigation].
Voprosy onkologii·2019
Enzalutamide alone or combined with other pharmacologic agents for metastatic castration-resistant prostate cancer: A systematic review and meta-analysis.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026
Nivolumab dose stewardship in routine Oncology practice: a real-world health-economic simulation.
Expert review of pharmacoeconomics & outcomes research·2026
Impact of the Multimodal Protocol on the Outcomes of Cancer Patients Undergoing Radical Cystectomy.
Revista do Colegio Brasileiro de Cirurgioes·2026
An Optimized Cancer Cachexia Research Model.
Current protocols·2026
Vitamin C for the prevention of complex regional pain syndrome after foot and ankle fractures or surgery: a systematic review.
European review for medical and pharmacological sciences·2026
Macrophages Are Not Welcome: Potential of CCR1/CCR2 Inhibition for Cytokine Release Prevention.
Cancer immunology research·2026